Alicia Buck
- Co-authors
- Johan BylundKarin ChristensonGerrit HermannPetra HeffeterMichael WellerMarie‐Françoise RitzTala ShekarianNazanin Tatari
- Topics
- CAR-T cell therapy research (6 papers)Immunotherapy and Immune Responses (3 papers)CRISPR and Genetic Engineering (2 papers)
- Cited by
- ImmunologyOncologyMolecular Biology
- Journals
- SHILAP Revista de lepidopterologíaCancer ResearchInternational Journal of Molecular Sciences
- Partner nations
- United StatesSwitzerlandIreland
In The Last Decade
Alicia Buck
11 papers receiving 179 citations
Peers
Comparison fields: 5 of 49
- Immunology 84
- Molecular Biology 83
- Oncology 65
- Organic Chemistry 21
- Cell Biology 15
Countries citing papers authored by Alicia Buck
This map shows the geographic impact of Alicia Buck's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Alicia Buck with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Alicia Buck more than expected).
Fields of papers citing papers by Alicia Buck
This network shows the impact of papers produced by Alicia Buck. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Alicia Buck. The network helps show where Alicia Buck may publish in the future.
Co-authorship network of co-authors of Alicia Buck
This figure shows the co-authorship network connecting the top 25 collaborators of Alicia Buck. A scholar is included among the top collaborators of Alicia Buck based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Alicia Buck. Alicia Buck is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 8 | |
| 2 | 11 | |
| 3 | 1 | |
| 4 | 47 | |
| 5 | 1 | |
| 6 | 24 | |
| 7 | 17 | |
| 8 | 2 | |
| 9 | 23 | |
| 10 | 44 | |
| 11 | [In vitro hemolysis in visible light in porphyria and light dermatosis without disorders of porphyrin metabolism]. | 3 |
About Alicia Buck
Alicia Buck is a scholar working on Immunology, Oncology and Neurology, having authored 11 papers that have together received 181 indexed citations. Recurring topics across this work include CAR-T cell therapy research (6 papers), Immunotherapy and Immune Responses (3 papers) and CRISPR and Genetic Engineering (2 papers). The work is most often cited by research in Immunology (84 citations), Oncology (65 citations) and Molecular Biology (83 citations). Alicia Buck has collaborated with scholars based in United States, Switzerland and Ireland. Frequent co-authors include Johan Bylund, Karin Christenson, Gerrit Hermann, Petra Heffeter, Michael Weller, Marie‐Françoise Ritz, Tala Shekarian, Nazanin Tatari, Berend Snijder and Vignesh Venkatakrishnan. Their work appears in journals such as SHILAP Revista de lepidopterología, Cancer Research and International Journal of Molecular Sciences.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.